The pharma company mounts a strategic comeback

Moderna surges after cancer vaccine trials as Klarna suffers in Germany

South Africa’s drugmakers say government procurement is killing local manufacturing, threatening 2,500 jobs and worsening medicine supply risks, despite commitments to…

The top court struck down the state’s certificate-of-need scheme. It serves as a warning to NHI’s architects: good intentions aren’t enough

While legal challenges to NHI play out, it’s crucial that the healthcare system remains stable, functioning – and moving forwards

PMBs cover 271 conditions and cost medical schemes R135bn a year – but complex rules mean members can still face massive out-of-pocket costs

Despite the president’s assertions, neither the Freedom Charter nor the UN say that the ANC’s NHI is the only option to achieve universal health coverage

Alex van den Heever says NHI lacks the legal, fiscal and constitutional foundations to work, while urgent health reforms have been sidelined.

Discovery’s CEO has brushed off a market bruising, with a growth target of 15%-20% from here on out

Discovery poured R15bn into launching its bank. With SA’s fragile economy squeezing its medical business, it’s a good thing the bank is in the black